{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T14:27:12Z","timestamp":1760452032741,"version":"3.41.2"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1999,4,1]],"date-time":"1999-04-01T00:00:00Z","timestamp":922924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1999,4,1]],"date-time":"1999-04-01T00:00:00Z","timestamp":922924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[1999,4]]},"DOI":"10.1023\/a:1018827214223","type":"journal-article","created":{"date-parts":[[2003,2,19]],"date-time":"2003-02-19T16:23:59Z","timestamp":1045671839000},"page":"549-554","source":"Crossref","is-referenced-by-count":37,"title":["Design and Evaluation of an Osmotic Pump Tablet (OPT) for Chlorpromazine Using (SBE)7m-\u03b2-CD"],"prefix":"10.1007","volume":"16","author":[{"given":"Kazuto","family":"Okimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuo","family":"Ohike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rinta","family":"Ibuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Ohnishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsumi","family":"Irie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaneto","family":"Uekama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger A.","family":"Rajewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentino J.","family":"Stella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"volume-title":"Medical applications of controlled release","year":"1984","key":"303544_CR1","unstructured":"R. S. Langer and D. L. Wise (Ed.). Medical applications of controlled release. Vol. I, II, CRC Press, Inc., Boca Raton (1984)."},{"key":"303544_CR2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2165\/00003088-198409020-00001","volume":"9","author":"L. Hendeles","year":"1984","unstructured":"L. Hendeles, R. P. Iafrate, and M. Weinberger. A clinical and pharmacokinetics basis for the selection and use of slow release theophylline products. Clin. Pharmacokin.\n9:95\u2013135 (1984).","journal-title":"Clin. Pharmacokin."},{"key":"303544_CR3","volume-title":"In rate control in drug therapy","author":"R. G. Shanks","year":"1985","unstructured":"R. G. Shanks. In rate control in drug therapy. L. F. Prescott and W. S. Nimmo (Ed.), Churehill Livingstone, Edinburgh (1985)."},{"key":"303544_CR4","unstructured":"V. A. John. Proceedings of the First European Congress of Biopharmaceutics and Pharmacokinetics. Vol. I: J. M. Aiache and J. Hirtz (Ed.), Paris Technique et Documentation (1981)."},{"key":"303544_CR5","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1002\/jps.2600641218","volume":"64","author":"F. Theeuwes","year":"1975","unstructured":"F. Theeuwes. Elementary osmotic pump. J. Pharm. Sci.\n64:1987\u20131991 (1975).","journal-title":"J. Pharm. Sci."},{"key":"303544_CR6","first-page":"35","volume":"5","author":"B. Eckenhoff","year":"1981","unstructured":"B. Eckenhoff, F. Theeuwes, and J. Urquhart. Osmotically actuated dosage forms for rate-controlled drug delivery. Pharm. Techn.\n5:35\u201344 (1981).","journal-title":"Pharm. Techn."},{"key":"303544_CR7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0168-3659(85)90047-1","volume":"2","author":"G. M. Zentner","year":"1985","unstructured":"G. M. Zentner, G. S. Rork, and K. J. Himmelstein. Osmotic flow through controlled porosity films: An approach to delivery of water soluble compounds. J. Contr. Rel.\n2:217\u2013229 (1985).","journal-title":"J. Contr. Rel."},{"key":"303544_CR8","unstructured":"G. M. Zentner and G. S. Rork. Controlled porosity osmotic pump. U.S. Patent 4, 968, 507 (1990)."},{"key":"303544_CR9","unstructured":"K. Okimoto, R. A. Rajewski, and V. J. Stella. Release of testosterone from an osmotic pump tablet (OPT) utilizing (SBE)7m-\u03b2-CD as both a solubilizing and osmotic agent. J. Contr. Rel. (in press)."},{"key":"303544_CR10","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1023\/A:1011955117026","volume":"10","author":"K. Okimoto","year":"1998","unstructured":"K. Okimoto, M. Miyake, N. Ohnishi, R. A. Rajewski, V. J. Stella, T. Irie, and K. Uekama. Design and evaluation of an osmotic pump tablet (OPT) for prednisolone, a poorly water soluble drug, using (SBE)7m-\u03b2-CD. Pharm. Res.\n10:1562\u20131567 (1998).","journal-title":"Pharm. Res."},{"key":"303544_CR11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0168-3659(97)01638-6","volume":"48","author":"J. S. Grundy","year":"1997","unstructured":"J. S. Grundy, K. E. Anderson, J. A. Rogers, and R. T. Foster. Studies on dissolution testing of the nifedipine gastrointestinal therapeutic system. II. Improved in vitro-in vivo correlation using a two-phase dissolution test. J. Contr. Rel.\n48:9\u201317 (1997).","journal-title":"J. Contr. Rel."},{"key":"303544_CR12","unstructured":"F. Theeuwes and T. Higuchi. Osmotic dispersing device for releasing beneficial agent. U.S. Patent 3, 845, 770, November 5, 1974."},{"key":"303544_CR13","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-2125.1982.tb01391.x","volume":"13","author":"M. J. Kendall","year":"1982","unstructured":"M. J. Kendall, D. B. Jack, K. L. Woods, S. J. Laugher, C. P. Quaterman, and V. A. John. Comparison of the pharmacodynamic and pharmacokinetic profiles of single and multiple doses of a commercial slow-release metoprolol formulation with a new Oros\u00ae delivery systen. Br. J. Clin. Pharmacol.\n13:393\u2013398 (1982).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"303544_CR14","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0168-3659(91)90047-H","volume":"16","author":"G. M. Zentner","year":"1991","unstructured":"G. M. Zentner, G. A. McClelland, and S. C. Sutton. Controlled porosity solubility-and resin-modulated osmotic drug delivery systems for release of diltiazem hydrochloride. J. Contr. Rel.\n16:237\u2013244 (1991).","journal-title":"J. Contr. Rel."},{"key":"303544_CR15","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/jps.2600791017","volume":"79","author":"R. Bodmeier","year":"1990","unstructured":"R. Bodmeier and O. Paeratakul. Theophylline tablets coated with aqueous latexes containing dispersed pore formers. J. Pharm. Sci.\n79:925\u2013928 (1990).","journal-title":"J. Pharm. Sci."},{"key":"303544_CR16","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0168-3659(95)00028-7","volume":"35","author":"S. M. Herbig","year":"1995","unstructured":"S. M. Herbig, J. R. Cardinal, R. W. Korsmeyer, and K. L. Smith. Asymmetric-membrane tablet coatings for osmotic drug delivery. J. Contr. Rel.\n35:126\u2013136 (1995).","journal-title":"J. Contr. Rel."},{"key":"303544_CR17","unstructured":"V. J. Stella and R. A. Rajewski. Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the pharmaceutical use thereof. U.S. Patent 5, 134, 127, July 18, 1992."},{"key":"303544_CR18","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1023\/A:1016047215907","volume":"13","author":"K. Okimoto","year":"1996","unstructured":"K. Okimoto, R. A. Rajewski, K. Uekama, J. A. Jona, and V. J. Stella. The interaction of charged and uncharged drugs with neutral (HP-\u03b2-CD) and anionically charged (SBE7-\u03b2-CD) \u03b2-cyclodextrins. Pharm. Res.\n13:256\u2013264 (1996).","journal-title":"Pharm. Res."},{"key":"303544_CR19","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1021\/js960236u","volume":"86","author":"V. Zia","year":"1997","unstructured":"V. Zia, R. A. Rajewski, E. R. Bornancini, E. A. Luna, and V. J. Stella. Effect of alkyl chain length and degree of substitution on the complexation of sulfoalkyl ether \u03b2-cyclodextrins with steroids. J. Pharm. Sci.\n86:220\u2013224 (1997).","journal-title":"J. Pharm. Sci."},{"key":"303544_CR20","first-page":"117","volume-title":"Advances in Analytical Chemistry and Instrumentation","author":"T. Higuchi","year":"1965","unstructured":"T. Higuchi and K. Connors. Phase-solubility techniques, in: C. N. Reilly (Ed.), Advances in Analytical Chemistry and Instrumentation, Interscience, New York, 1965, pp. 117\u2013212."},{"key":"303544_CR21","first-page":"294","volume-title":"Controlled drug delivery","author":"J. P. Skelly","year":"1987","unstructured":"J. P. Skelly. Controlled drug delivery. J. R. Robinson and V. H. Lee (Ed.), Marcel Dekker Inc., New York, 294 (1987)."},{"key":"303544_CR22","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/j.1552-4604.1982.tb02660.x","volume":"22","author":"M. C. Meyer","year":"1982","unstructured":"M. C. Meyer, A. B. Straughn, P. Lieberman, and J. Jacob. Serious bioavalability problems with a generic prolonged-release quinidine gluconate product. J. Clin. Pharmacol.\n22:131\u2013134 (1982).","journal-title":"J. Clin. Pharmacol."},{"key":"303544_CR23","first-page":"496","volume":"23","author":"N. Aoyagi","year":"1985","unstructured":"N. Aoyagi, H. Ogata, N. Kaniwa, and A. Ejima. Bioavailability of indomethacin capsules in humans (1): Bioavailability and effects of gastric acidity. Int. J. Clin. Pharmacol. Ther. Toxicol.\n23:496\u2013474 (1985).","journal-title":"Int. J. Clin. Pharmacol. Ther. Toxicol."},{"key":"303544_CR24","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1023\/A:1015970512368","volume":"7","author":"J. P. Skelly","year":"1990","unstructured":"J. P. Skelly, G. L. Amidon, W. H. Barr, L. Z. Benet, J. R. Carter, J. R. Robinson, V. P. Shah, and A. Yacobi. In vitro and in vivo testing and correlation for oral controlled\/modified-release dosage forms. Pharm. Res.\n7:975\u2013982 (1990).","journal-title":"Pharm. Res."},{"key":"303544_CR25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF01066595","volume":"3","author":"J. G. Wagner","year":"1975","unstructured":"J. G. Wagner. Application of the Loo-Riegelman absorption method. J. Pharmacokin. Biopharm.\n3:51 (1975).","journal-title":"J. Pharmacokin. Biopharm."}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1018827214223.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1018827214223\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1018827214223.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T07:39:38Z","timestamp":1754033978000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1018827214223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,4]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1999,4]]}},"alternative-id":["303544"],"URL":"https:\/\/doi.org\/10.1023\/a:1018827214223","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"type":"print","value":"0724-8741"},{"type":"electronic","value":"1573-904X"}],"subject":[],"published":{"date-parts":[[1999,4]]}}}